measure relevant stability indicators (e.g., appearance, pH, potency), and document results.

Quality Control (QC): Ensure that all stability testing complies with regulatory standards, and assess the impact of storage conditions on the quality attributes of the formulation.

Project Managers: Coordinate the stability study timelines, manage resources, and ensure that stability testing is conducted according to the study design and regulatory guidelines.

4) Procedure

The following steps outline the procedure for assessing storage conditions for formulation stability:

1. Step 1: Define Storage Conditions
   1. Determine the recommended storage conditions for the formulation based on its composition, API characteristics, and intended use (e.g., oral, topical, injectable).
   2. Consider factors such as temperature (e.g., room temperature, refrigerated, frozen), humidity, light exposure, and packaging material (e.g., glass, plastic, blister packs) when setting storage parameters.
   3. For controlled temperature storage, define acceptable temperature ranges, such as 25°C ± 2°C for room temperature or 2-8°C for refrigerated storage.
   4. If applicable, define storage conditions for special formulations such as freeze-dried (lyophilized) products or light-sensitive compounds.
2. Step 2: Initiate Stability Studies
   1. Prepare the formulation samples according to the batch or prototype being evaluated for stability.
   2. Distribute the formulation samples into appropriate containers (e.g., vials, bottles, blisters) and seal them according to the intended storage conditions.
   3. Label each sample with the storage conditions, batch number, and time points for stability analysis (e.g., 0, 3, 6, 12 months).
3. Step 3: Monitor Storage Conditions
   1. Store the samples in designated stability chambers or storage areas that can maintain the specified temperature and humidity conditions.
   2. Use environmental monitoring equipment to regularly check and record the temperature, humidity, and light exposure within the storage area.
   3. Ensure that temperature-controlled storage units (e.g., refrigerators, freezers) are equipped with data loggers to track and record environmental conditions throughout the study period.
   4. Conduct periodic checks to ensure that the storage conditions remain stable and consistent with the defined parameters.
4. Step 4: Conduct Stability Testing
   1. At the specified time points (e.g., 0, 3, 6, 12 months), retrieve the samples from storage and evaluate their stability by testing the following parameters:
      • Physical appearance (e.g., color, consistency, clarity, phase separation)
      • Chemical integrity (e.g., potency, degradation products)
      • pH or other relevant chemical properties
      • Microbiological quality (if applicable)
      • Dissolution or drug release rate (if applicable)
   2. Compare the results from each time point to the baseline (0-month) data to assess the impact of storage conditions on formulation stability.
   3. If applicable, conduct accelerated stability testing at higher temperatures (e.g., 40°C ± 2°C, 75% RH) to predict long-term stability and understand how the formulation behaves under stress conditions.
5. Step 5: Analyze Results and Draw Conclusions
   1. Analyze the stability data by comparing results from different time points, considering acceptable limits for each stability parameter (e.g., API content, pH, appearance, etc.).
   2. If significant degradation or changes in the formulation occur, assess whether adjustments in storage conditions or formulation adjustments are necessary to improve stability.
   3. Evaluate whether the formulation meets the established stability criteria for each storage condition, and identify any conditions that may cause instability (e.g., temperature fluctuations, excessive humidity, light exposure).
6. Step 6: Document and Report Findings
   1. Document all storage conditions, stability testing parameters, and results in the stability study report, including raw data, observations, and analysis.
   2. Prepare a summary report that includes conclusions regarding the formulation’s stability under different storage conditions, recommended storage conditions, and any required corrective actions (if applicable).
   3. Ensure that all records are signed, dated, and stored in compliance with Good Laboratory Practices (GLP) and regulatory standards.
7. Step 7: Sample Disposal
   1. Dispose of any remaining test samples, solvents, and materials according to safety protocols and environmental regulations.
   2. Ensure that hazardous materials are disposed of in designated chemical waste containers in compliance with safety guidelines.

5) Documents

The following documents should be maintained during the stability testing of formulations under different storage conditions:

1. Stability Study Protocol
2. Environmental Monitoring Records
3. Stability Testing Reports
4. Raw Data and Observations
5. Stability Study Summary Report
6. Sample Disposal Records

6) Abbreviations

• API: Active Pharmaceutical Ingredient
• GLP: Good Laboratory Practices
• HPLC: High-Performance Liquid Chromatography
• RH: Relative Humidity
• USP: United States Pharmacopeia

7) References

References to regulatory guidelines and scientific literature that support this SOP:

• FDA Guidance for Pharmaceutical Stability Studies
• USP <1079> on Stability Testing
• ICH Q1A(R2) Stability Testing of New Drug Substances and Products

8) Version

Version 1.0: Initial version of the SOP.

9) Annexure

Stability Study Results Template

Formulation ID	Storage Conditions	Time Point	Physical Appearance	Potency (%)	pH	Remarks